Key Insights

Highlights

Treatment Research

1 treatments under study, led by Artesunate

Research Leaders

5 sponsors active, led by Anal Dysplasia Clinic MidWest

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05555862Phase 2Active Not Recruiting

Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

Showing all 1 trials

Research Network

Common Treatments

  • Artesunate1

Active Sponsors

  • Anal Dysplasia Clinic MidWest1
  • University of California, San Francisco1
  • Laser Surgery Care1
  • Amarex CRO1
  • Frantz Viral Therapeutics, LLC1

Top Investigators

Related Conditions

  • Hpv Disease1
  • Hpv Infection1
  • Anal High Grade Squamous Intraepithelial Lesion1
  • Anal Precancerous Condition1
  • Anal Dysplasia1

Activity Timeline